These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 394138)
1. Does aspirin prevent stroke? Mitchell JR Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138 [No Abstract] [Full Text] [Related]
2. Aspirin to prevent a stroke? N Z Med J; 1978 Oct; 88(621):286-7. PubMed ID: 364347 [No Abstract] [Full Text] [Related]
3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
4. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents]. Bousser MG J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494 [TBL] [Abstract][Full Text] [Related]
5. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease. Friedman LM Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355 [TBL] [Abstract][Full Text] [Related]
6. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions]. Ostendorf P Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265 [No Abstract] [Full Text] [Related]
7. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes]. Bousser MG Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464 [No Abstract] [Full Text] [Related]
8. Platelet inhibitors in the treatment of thrombosis. Hirsh J Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458 [No Abstract] [Full Text] [Related]
9. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977 [No Abstract] [Full Text] [Related]
11. Current therapy of cerebrovascular disease. Wilkerson RJ; Liem PH; Carter WJ J Ark Med Soc; 1984 Apr; 80(11):539-45. PubMed ID: 6234289 [No Abstract] [Full Text] [Related]
12. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related]
14. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
15. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"]. Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110 [No Abstract] [Full Text] [Related]
16. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction. Hirsh J Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733 [TBL] [Abstract][Full Text] [Related]
17. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease. Millikan CH Trans Am Neurol Assoc; 1973; 98():206-18. PubMed ID: 4784937 [No Abstract] [Full Text] [Related]
18. The Canadian trial of aspirin and sulfinpyrazone in threatened stroke. Whisnant JP Am Heart J; 1980 Jan; 99(1):129-30. PubMed ID: 6985763 [No Abstract] [Full Text] [Related]
19. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]